Experimental weight-loss drug Retatrutide shows promise, helping obese adults lose up to 22% of their weight in 48 weeks.

I attended my high school reunion and had no anxiety about appearance,” Sarah gushed. “My new problem was graciously ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo ...

Ozempic, a weight-loss breakthrough with semaglutide, is revolutionizing fat reduction. Offering faster, more effective ...

TOWIE star Amy Childs was dealt a crushing blow as her luxury New Year getaway ended in disaster. The mum-of-four has been enjoying a sun-soaked break in the Canary Islands with her family but ...

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

SHOPPING: Lose weight for Less! Transform your health this New Year with 30% off the #1 affordable Ozempic alternative.

Just type in #weightloss on any social media platform today and you'll be met with everything from intermittent fasting diets ...

Novo Nordisk's prospects look attractive despite a recent clinical setback. AstraZeneca would be performing well if not for ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 489.81% and ...

Structure Therapeutics has a strong cash position with a runway of 18-20 quarters, but the drug's potential is not fully ...

Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...